FDA Approves Eli Lilly's GLP-1 Pill
Eli Lilly’s once-daily Foundayo is the second obesity pill to receive FDA approval. It will compete with Novo Nordisk’s pill version of Wegovy.
schedule
18:56
visibility
44 مشاهدة
المصدر: Wired
قراءة المقال الأصلي →
auto_awesome تمت ترجمة هذا المقال آليًا وقد يحتوي على أخطاء.
Eli Lilly’s once-daily Foundayo is the second obesity pill to receive FDA approval. It will compete with Novo Nordisk’s pill version of Wegovy.